Cytosorbents (CTSO) Misses Q4 EPS by 8c

Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.21), $0.08 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $10.11 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Evogene (EVGN) Tops Q2 EPS by 15c
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c